Literature DB >> 33765242

Efficient Stable Cell Line Generation of Survivin as an In Vitro Model for Specific Functional Analysis in Apoptosis and Drug Screening.

Rashid Houshdarpour1, Farangis Ataei2, Saman Hosseinkhani1.   

Abstract

Recognizing proteins that lead to a decreased efficiency of treatment in cancer cells constitutes a main goal for biomedical and biotechnological research and applications. Establishing recombinant cells that overexpress a gene of interest stably is important for treatment studies and drug/compound screening. Survivin is an anti-apoptotic protein which can be a potential candidate for regulating cell death and survival. To investigate the association between survivin increment and apoptosis rate, survivin-reconstituted HEK (HEK-S) cell was developed as in vitro model. RT-PCR and Western blot demonstrated that survivin was constitutively overexpressed in HEK-S cells. Both morphological observation and survival assay showed that HEK-S cells were significantly resistant to apoptotic stimuli. Survivin overexpression led to a decrease in caspase 3/7 activity, whereas YM155 led to a corresponding enhance of caspase activity. ROS level was decreased but ATP content increased in HEK-S cells. Also, HEK-S showed less red- fluorescence and reduced cell proliferation compared to HEK after stimulation. Resistance to laser irradiation was clearly visible as compared with control. Moreover, scratching analysis demonstrated the ability of survivin to cause neighboring cells to increase resistance to drug, whereas YM155 enhanced apoptotic rate and declined invasion in HEK-S cells.

Entities:  

Keywords:  Apoptosis; Stable cells; Survivin; YM155

Mesh:

Substances:

Year:  2021        PMID: 33765242     DOI: 10.1007/s12033-021-00313-y

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  1 in total

1.  Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.

Authors:  K Tanaka; S Iwamoto; G Gon; T Nohara; M Iwamoto; N Tanigawa
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

  1 in total
  3 in total

1.  Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel.

Authors:  Kayhan Mehdizadeh; Farangis Ataei; Saman Hosseinkhani
Journal:  Med Oncol       Date:  2021-04-27       Impact factor: 3.064

Review 2.  XIAP as a multifaceted molecule in Cellular Signaling.

Authors:  Mina Hanifeh; Farangis Ataei
Journal:  Apoptosis       Date:  2022-06-04       Impact factor: 5.561

3.  Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug.

Authors:  Meysam Bakhshoudeh; Kayhan Mehdizadeh; Saman Hosseinkhani; Farangis Ataei
Journal:  Med Oncol       Date:  2021-06-28       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.